Limitations of rat carotid balloon de-endothelialization model in arterial photodynamic therapy: a study using 5-aminolaevulinic acid

Isaac Nyamekye; Alexander J. MacRobert; Christopher C. R. Bishop; Stephen G. Bown

doi:10.1117/12.209070

12 May 1995 Limitations of rat carotid balloon de-endothelialization model in arterial photodynamic therapy: a study using 5-aminolaevulinic acid

Isaac Nyamekye, Alexander J. MacRobert, Christopher C. R. Bishop, Stephen G. Bown

Author Affiliations +

Proceedings Volume 2395, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems V; (1995) https://doi.org/10.1117/12.209070
Event: Photonics West '95, 1995, San Jose, CA, United States

Abstract

Photodynamic therapy (PDT) effectively inhibits fibrocellular intimal hyperplasia (FCIH) two and four weeks after arterial traction balloon injury in rat carotid arteries. The aim of the present study was to assess the long term effects of PDT in this rat model of FCIH. 5- aminolaevulinic acid-induced protoporphyrin IX was used to sensitize rats for PDT after traction balloon arterial injury to the whole of the left common carotid artery. Rats were sacrificed at intervals of six to 26 weeks, and perfusion fixed and H and E stained sections were analyzed using computerized morphometry. PDT inhibition of FCIH was only partial at these late times. The amount of FCIH present increased with increasing time after injury. The late occurrence of FCIH appeared to be due to migration of FCIH from balloon injured areas outside the PDT treated field as a result of the traction injury being applied to the whole carotid. We recommend segmental balloon injury rather than the traction injury of the whole common carotid injury for future studies in this model.

Citation Download Citation

Isaac Nyamekye, Alexander J. MacRobert, Christopher C. R. Bishop, and Stephen G. Bown "Limitations of rat carotid balloon de-endothelialization model in arterial photodynamic therapy: a study using 5-aminolaevulinic acid", Proc. SPIE 2395, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems V, (12 May 1995); https://doi.org/10.1117/12.209070

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available